# EDGAR Filing Document

**Accession Number:** 0001517681
**File Stem:** 0001493152-26-006497
**Filing Date:** 2026-2
**Character Count:** 2043
**Document Hash:** 502d7bb6b6c3807667a0405778a75aef
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-006497.hdr.sgml**: 20260528

**ACCESSION NUMBER**: 0001493152-26-006497

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260212

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Propanc Biopharma, Inc.
- **CENTRAL INDEX KEY:** 0001517681
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 330662986
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 302/6 BUTLER STREET
- **CITY:** CAMBERWELL, VICTORIA
- **STATE:** C3
- **ZIP:** 3124
- **BUSINESS PHONE:** 61-03-9882-0780

**MAIL ADDRESS:**
- **STREET 1:** 302/6 BUTLER STREET
- **CITY:** CAMBERWELL, VICTORIA
- **STATE:** C3
- **ZIP:** 3124

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Propanc Health Group Corp
- **DATE OF NAME CHANGE:** 20110408

United States Securities and Exchange Commission

Division of Corporation Finance

Attn: Jimmy McNamara

100 F Street, N.E.

Washington, DC 20549

---

| | |
|:---|:---|
| **Re:** | **Propanc Biopharma, Inc.** |
|  | **Registration Statement on Form S-1** |
|  | **Filed February 2, 2026** |
|  | **File No. 333-293147** |

---

**REQUEST FOR WITHDRAWAL OF ACCELERATION OF EFFECTIVENESS**

Ladies and Gentlemen:

Reference is made to our letter, dated February 10, 2026 in which we requested acceleration of the effective date of the above referenced Registration Statement to February 12, 2026 at 9:30 a.m. Eastern Standard Time. We are no longer requesting that such Registration Statement be declared effective at such time, and we hereby formally, and with immediate effect, withdraw our request for acceleration of the effective date.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Propanc Biopharma, Inc. | Propanc Biopharma, Inc. |
| By: | */s/ James Nathanielsz* |
| Name: | James Nathanielsz |
| Title: | Chief Operating Officer |

---